Toll-Like Receptors Agonists: First-Line Defense Tools in the Pandemic Preparedness Arsenal?
Arch Iran Med
.
2024 Nov 1;27(11):629-632.
doi: 10.34172/aim.31792.
Epub 2024 Nov 1.
Authors
Farrokh Habibzadeh
1
,
Parham Habibzadeh
2
,
Mihai G Netea
3
4
,
Mahboobeh Yadollahie
5
Affiliations
1
Independent Research Consultant, Shiraz, Iran.
2
Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
3
Radboud Center for Infectious Diseases, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
4
Department of Immunology and Metabolism, Life and Medical Science Institute, University of Bonn, Bonn, Germany.
5
Independent Researcher, Shiraz, Iran.
PMID:
39534998
PMCID:
PMC11558610
DOI:
10.34172/aim.31792
No abstract available